Herpes Simplex Virus Type 2 Vaccines: New Ground for Optimism?
The development of effective prophylactic and therapeutic vaccines against genital herpes has proven problematic. Difficulties are associated with the complexity of the virus life cycle (latency) and our relatively poor understanding of the mechanism of immune control of primary and recurrent diseas...
Shranjeno v:
| izdano v: | Clin Diagn Lab Immunol |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Microbiology (ASM)
2004
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC404574/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15138167/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/CDLI.11.3.437-445.2004 |
| Oznake: |
Brez oznak, prvi označite!
|